V tem primeru je morda primerna za klinično raziskovalno študijo ASPECT™. Namen te študije je oceniti varnost in učinkovitost preiskovanega zdravila za vznemirjenost, povezano z Alzheimerjevo demenco.
S študijo ASPECT se lahko naučimo več o morebitnem zdravljenju vznemirjenosti pri bolnikih z Alzheimerjevo demenco.
biti stari med 50 in 90 let (vključno);
imeti diagnosticirano verjetno Alzheimerjevo demenco;
biti zmerno do hudo vznemirjeni, kar vpliva na njihovo vsakodnevno življenje;
imeti zanesljivega skrbnika, ki vsaj 4 dni na teden vsaj 2 uri na dan preživi z njimi ter je pripravljen in zmožen upoštevati vse postopke študije.
Veljali bodo drugi kriteriji primernosti.
Viri:
1 Cummings J, et al. “Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition.” International Psychogeriatrics, 27:1, 7–17. 2015. https://www.ncbi.nlm.nih.gov/pubmed/25311499
2 Knapp M, et al. “Predictors of care home and hospital admissions and their costs for older people with Alzheimer’s disease: findings from a large London case register.” BMJ Open, 6:11, 1-15. 2016. https://bmjopen.bmj.com/content/bmjopen/6/11/e013591.full.pdf
3 DeTure MA, et al. The neuropathological diagnosis of Alzheimer’s disease. Molecular Neurodegeneration. 2019;14:32;doi.org/10.1186/s13024-019-0333-5
4 Alzheimer’s Association. “2017 Alzheimer’s Disease Facts and Figures.” Alzheimer’s & Dementia, 13: 325-373. April 2017. https://www.sciencedirect.com/science/article/pii/S1552526017300511?viewFullText=true
5 Laybourne A, et al. “Carer coping and resident agitation as predictors of quality of life in care home residents living with dementia: Managing Agitation and Raising Quality of Life (MARQUE) English national care home prospective cohort study.” International Journal Of Geriatric. Psychiatry, 34:106-113. 2018. https://www.ncbi.nlm.nih.gov/pubmed/30276865
6 Rabins P, et al. “Neuropsychiatric symptoms at baseline predict shorter time to severe dementia in a population-based sample of incident Alzheimer’s disease: The Cache County dementia progression study.” Alzheimer’s and Dementia, supplement, 8.4: 126-127. 2012. https://www.alzheimersanddementia.com/article/S1552-5260(12)00465-7/abstract
7 Peters M, et al. “Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: The Cache County Dementia Progression Study.”172(5): 460-5. 2015. https://www.ncbi.nlm.nih.gov/pubmed/25585033.
© 2022–2024 Clinical Trial Media. Vse pravice pridržane.